Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32211
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLim Joon, Daryl-
dc.contributor.authorBerry, Colleen-
dc.contributor.authorHarris, Benjamin-
dc.contributor.authorTacey, Mark A-
dc.contributor.authorSmith, Drew-
dc.contributor.authorLawrentschuk, Nathan-
dc.contributor.authorSchneider, Michal Elisabeth-
dc.contributor.authorFraser, Olivia-
dc.contributor.authorHall, Megan-
dc.contributor.authorChao, Michael-
dc.contributor.authorForoudi, Farshad-
dc.contributor.authorJenkins, Trish-
dc.contributor.authorAngus, David-
dc.contributor.authorWada, Morikatsu-
dc.contributor.authorSengupta, Shomik-
dc.contributor.authorKhoo, Vincent-
dc.date2023-
dc.date.accessioned2023-03-01T03:55:56Z-
dc.date.available2023-03-01T03:55:56Z-
dc.date.issued2022-
dc.identifier.citationFrontiers in Oncology 2022; 12en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/32211-
dc.description.abstractImage guidance with gold fiducials improves outcomes of prostate radiotherapy. However, gold produces artefact on CT imaging, interfering with contouring and verification. The purpose of this study was to compare polymer to standard gold fiducials using radiotherapy imaging modalities to assess the visibility and artefact.en_US
dc.language.isoeng-
dc.subjectimage guided radiotherapyen_US
dc.subjectpolymer fiducialsen_US
dc.subjectprostate canceren_US
dc.subjectradiotherapyen_US
dc.subjectverificationen_US
dc.titleA clinical study comparing polymer and gold fiducials for prostate cancer radiotherapy.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleFrontiers in Oncologyen_US
dc.identifier.affiliationRadiation Oncologyen_US
dc.identifier.affiliationOlivia Newton-John Cancer Wellness and Research Centreen_US
dc.identifier.affiliationOffice of Research, The Northern Hospital, Epping, VIC, Australia.en_US
dc.identifier.affiliationAustin Healthen_US
dc.identifier.affiliationDepartment of Medical Imaging and Radiation Sciences, Monash University, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationDepartment of Clinical Oncology, Royal Marsden Hospital, London, United Kingdom.en_US
dc.identifier.doi10.3389/fonc.2022.1023288en_US
dc.type.contentTexten_US
dc.identifier.pubmedid36818674-
dc.description.volume12-
dc.description.startpage1023288-
local.name.researcherAngus, David
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
crisitem.author.deptRadiation Oncology-
crisitem.author.deptRadiation Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptRadiation Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptRadiation Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptRadiation Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptUrology-
crisitem.author.deptSurgery-
crisitem.author.deptRadiation Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptUrology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

64
checked on Nov 4, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.